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Purpose: In the present study, six flavonoids (5,7-dimethoxyflavanone-4’-O-β-D-glucopyranoside, 5,7-
dimethoxyflavanone-4’-O-[2’’-O-(5’’’-O-trans-cinnamoyl)-β-D-apiofuranosyl]-β-D-glucopyranoside, 
naringenin-7-O-β-D-glucopyranoside, 5,7,3’-trihydroxy-flavanone-4’-O-β-D-glucopyranoside, rutin, and 
nicotiflorin) isolated from Galium fissurense, Viscum album ssp. album and Cirsium hypoleucum were 
screened against extended-spectrum β-lactamase producing multidrug-resistant (trimetoprime-
sulphametoxazole, sulbactam-ampicillin, clavulonate-amoxicilin, ceftriaxon,  cefepime, imipenem, 
ceftazidime, tobramicin, gentamicin, ofloxacin, ciprofloxacin) bacteria Klebsiella pneumoniae (ESβLs).  
Methods: We performed susceptibility testing according to the Clinical and Laboratory Standards 
Institute (CLSI, formerly NCCLS) and used an inhibition endpoint for determination of the minimum 
inhibition concentrations (MICs).  
Results: All the flavonoids showed in vitro antimicrobial activity against all the isolated strains of K. 
pneumoniae similar to the control antibacterial (ofloxacin) at the concentrations of 32 - 64 µg ml-l; 
another control, ampicillin, had no activity. Since, ESβL-producing strains are known to be resistant to 
all β-lactam antibiotics, our results fall notably within the concentration range for antimicrobial activity.  
Conclusion: To the best of our knowledge, this is the first report of the study of the activity of these 
flavonoids against (ESβL)-producing K. pneumoniae and may throw light to the low-toxicity of 
flavonoids, and their potentials for developing therapies for infections caused by ESβL-producing 
bacteria in the future. Further work is under investigation to identify their precise antibacterial 
mechanism.  
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INTRODUCTION 
Multiple drug resistance has significantly 
increased in recent years. The existence of 
enzymes of extended-spectrum β-lactamases 
(ESβLs) producing organism that are resistant 
to virtually all β-lactam antibiotics have been 
reported
1
. ESβLs are plasmid-mediated class 
A enzymes commonly found in the family 
Enterobacteriaceae, mainly K. pneumoniae2. 
These microorganisms are Gram-negative 
rods that cause bacterial pneumonia and 
hospital-acquired infections
3
. The increase in 
ESβL-producing organisms is sure to create 
significant therapeutic problems in the future. 
The available treatment regimens for 
infections caused by ESβL-producing bacteria 
are not always effective. Therefore, it is 
necessary to discover new antimicrobial 
compounds against ESβL-producing K. 
pneumoniae strains. 
Flavonoids occur as aglycones, glycosides 
and methylated derivatives and are widely 
distributed in the plant kingdom. They have 
been reported to possess a variety of 
biological activities including antiallergic, 
antidiabetic, antiinflammatory, antiviral, 
antiproliferative and anticarcinogenic, 
hepatoprotective, and antioxidant activities. 
Since these secondary metabolites are 
synthesized by plants in response to microbial 
infection, it should not be surprising that they 
have been found in vitro to be effective 
antimicrobial substances against a wide array 
of microorganisms
4-6
. Also, their antimicrobial 
activities against some Gram-negative and 
Gram-positive bacteria have been reported in 
many papers
2
. Therefore, the flavonoids may 
be promising new class compounds in 
antimicrobial therapy.  
In this study, six flavonoids isolated from three 
medicinal plants, which are used in Turkish 
folk medicine, were screened against K. 
pneumoniae. Galium fissurense Ehrend. & 
Schönb.-Tem. (Rubiaceae), which is an 
endemic plant in Turkey, has long been used 
in folk medicine for a variety of purposes, 
especially as a diuretic, astringent, choleretic 
and in the treatment of some stomach, gout 
and epilepsy
7
. Viscum album L. 
(Loranthaceae) is reported to have various 
biological activities such as hypoglycemic, 
anti-inflammatory, anti-viral, anti-atherogenic, 
and analgesic activities. On the other hand, 
we have previously shown that the extracts of 
V. album ssp. album have inhibitory effects on 
IL-1α
8
. In folk medicine, the decoction of 
Cirsium sp. (Asteraceae) seeds and roots is 
used for healing hemorrhoids and the flowers 
are a good remedy for peptic ulcer. In 
addition, the stem is also used for treating 
ailments such as cough and bronchitis in 
Anatolia
9. In a previous work of our group, the 
antimicrobial activities of various C. 
hypoleucum DC. extracts (methanol, n-
hexane, chloroform, ethylacetate, n-butanol 
and remaining water extracts) were tested 
against various microorganisms including 
Herpes simplex Type-1 (HSV-1) and 
Parainfluenza viruses (PIV)10.  
In this study, antimicrobial activity results of 
six flavonoids isolated from three plants used 
in traditional Turkish medicine against ten 
extended-spectrum β-lactamase producing 
multidrug - resistant (trimetoprime -
sulphametoxazole, sulbactam-ampicillin, 
clavulonate-amoxicilin, ceftriaxon,  cefepime, 
imipenem, ceftazidime, tobramicin, 
gentamicin, ofloxacin, ciprofloxacin) bacteria 
K. pneumoniae (ESβLs) were presented. In 
vitro broth microdilution testing was performed 
in accordance with the guidelines of CLSI. 
Ampicillin and ofloxacin were used as control 
agents while K. pneumoniae RSKK was used 





noside (1) was isolated from the ethylacetate 
extract of the leaves and stems of V. album 
ssp. album (Loranthaceae) from Armeniaca 
vulgaris Lam. by medium pressure liquid 
chromatography (MPLC) and 5,7-
dimethoxyflavanone-4’-O-[2’’-O-(5’’’-O-trans-
cinnamoyl)-β-D-apiofuranosyl]-β-D-glucopyra-
noside (2) was also isolated from the n-




A novel flavanone glucoside, 5,7,3’-trihydroxy-
flavanone-4’-O-β-D-glucopyranoside (3), was 
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isolated from the ethanol extract of the herb of 
G. fissurense, in addition to naringenin-7-O-β-
D-glucopyranoside (4)7.  From the n-butanol 
extract of C. hypoleucum aerial parts 
(Asteraceae), after multi-stage column 
chromatographies, two flavonoids, quercetin-
3-O-rutinoside (rutin) (5) and kaempferol-3-O-
rutinoside (nicotiflorin) (6) were previously 
obtained
9
. The structures of isolated 
compounds were elucidated by conventional 
methods of analysis, as well as by different 
NMR and MS techniques.  
 
Microbiological studies  
Preparation of the test materials 
The flavonoids were dissolved in 
dimethylsulphoxide to a concentration of 256 
µg ml
-1
 and sterilized by filtration using 0.22 
µm Millipore filter (MA 01730, USA) and then 
used as the stock solutions. Reference 
antibacterial agents of ampicillin (AMP; Faco), 
ofloxacin (OFX; Hoechst Marion Roussel) 
were obtained from their respective 
manufacturers and dissolved in phosphate 
buffer solution (ampicillin; pH: 8.0, 0.1 mol/L), 
and in water (ofloxacin). The stock solutions of 
these agents were prepared in medium 
according to as CLSI (formerly National 
Committee for Clinical Laboratory Standards) 




Microorganisms and Inoculum preparation 
Isolated strains of ten K. pneumoniae that are 
resistant to trimetoprime-sulphametoxazole 
(SXT; Oxoid; 25 µg; ≤10 mm), sulbactam-
ampicillin (SAM; Oxoid; 20 µg; ≤11 mm), 
clavulonate-amoxicilin (AMC; Oxoid; 20 µg; 
≤13 mm), ceftriaxon (CRO; Oxoid; 30 µg; ≤25 
mm),  cefepime (CPM; Oxoid; 30 µg; ≤14 
mm), imipenem (IMP; Oxoid;10 µg; ≤13 mm), 
ceftazidime (CAZ; Oxoid; 30 µg; ≤14 mm), 
tobramicin (TOB; Oxoid; 10 µg; ≤12 mm), 
gentamicin (GM; Oxoid; 10 µg; ≤12 mm), 
ofloxacin (OFX; Oxoid 5 µg; ≤12 mm), 
ciprofloxacin (CIP; Oxoid 5 µg; ≤13 mm) in 
disc diffusion test were used for the 
determination of antibacterial activity 
(minimum inhibition concentration, MIC). K. 
pneumoniae RSKK 574 (Refik Saydam 
Central Hygiene Institute-Culture Collection, 
The Ministry of Health of Republic of Turkiye, 
Ankara) was used as the control strain
12
. 
Mueller Hinton Broth (MHB; Oxoid) and 
Mueller Hinton Agar (MHA; Oxoid) were 
applied for growing and diluting of the bacteria 
suspensions. The microorganism suspensions 
used for inoculation were prepared at 10
7 
cfu 
(colony forming units)/ml by diluting fresh 





). Suspensions of all bacteria were added in 









Confirmatory test for ESβL-producing K. 
pneumoniae isolates 
The double-disc synergy and agar diffusion 
tests were used as screening tools to detect 
ESβL-producing strains. In the double-disc 
synergy test, the antibiotic discs (Oxoid) used 
were cefotaxime (30 µg) and ceftazidime (30 
µg) placed on Mueller-Hinton agar adjacent to 
a co-amoxiclav disc (20µg amoxicillin plus 
10µg clavulanate). The procedures and 
interpretation of the double-disc synergy test 
were described previously
14. The agar 
diffusion test was performed according to 
NCCLS guidelines
12
. A ≤5 mm increase in a 
zone diameter for either ceftazidime/clavulanic 
acid (30 µg/ 10 µg) or cefotaxime/clavulanic 
acid (30 µg/ 10 µg) versus its zone when 





Antimicrobial activity evaluation 
The microdilution method was employed for 
antibacterial tests. Media were placed into 
each 96 wells of the microplates. Sample 
solutions at 256 µg ml
-1
 were added into first 
rows of microplates and two-fold dilutions of 
the compounds (128-0.0312 µg ml
-1
) were 
made by dispensing the solutions into the 
remaining wells. 10 µl culture suspensions 
were inoculated into all the wells. The sealed 
microplates were incubated at 35ºC for 18h. 
The lowest concentration of the flavonoids 
that completely inhibit macroscopic growth 
was determined and the MICs were 
recorded
16
.    
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      1 R1= R2: - CH3, R3: -H, R4: -Glc  5  R: OH 
      3 R1= R2: - H, R3: -OH, R4: -Glc            6  R: H 

























Fig 1: Structures of investigated compounds 
 
RESULTS 
Antimicrobial effects of six flavonoids isolated 
from three Turkish plants on ten isolated 
strains of ESβL-containing K. pneumoniae are 
presented in Table 1. In our previous studies, 
we reported that two new flavonoids, 5,7,3’-
trihydroxy-flavanone-4’-O-β-D-
glucopyranoside (1) and 5,7-
dimethoxyflavanone-4’-O-[2’’-O-(5’’’-O-trans-
cinnamoyl)-β-D-apiofuranosyl]-β-D-
glucopyranoside (2), were isolated for the first 
time from V. album ssp. album and G. 
fissurense, respectively7,11. When compared 
with control agents (ampicillin and ofloxacin), 
all of the tested flavonoids (1-6) showed 
remarkable activities against isolated strains 
of all K. pneumoniae at 32 and 64 µg ml-1 
concentrations, which are close to the 
effective concentrations exhibited by the 
control agents. Notably, these compounds 
possessed quite remarkable antimicrobial 
activities against isolates, Kp3, Kp5, Kp6 and 
Kp10, similar ampicillin and ofloxacin (32 µg ml
-
1
). Isolates Kp1, Kp2, Kp4, Kp7-9 were inhibited 
at a concentration of 64 µg ml
-1
 by the tested 
flavonoids, the observed activities being twice 
the dose of ampicillin and ofloxacin (32 µg ml
-
1
). On the other hand, the activity at 8 µg ml
-1
 
concentration of the flavonoids (1-6) against 
K. pneumoniae RSKK 574 seems less active 
when compared with ampicillin (2 µg ml
-1
)  
and ofloxacin (<0.12 µg ml
-1
).  
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Table 1: Antimicrobial activity as MICs (µg ml-1) of flavonoids and the references against tested isolated  
strains of Klebsiella pneumoniae (Kpn: 1-10) 
 
Microorganisms 
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64 64 32 64 32 32 64 64 64 32 8 
Ampicillin 
 - - - - - - - - - - 2 
Ofloxacin  32 32 32 32 32 32 32 32 32 32 <0.12 
 
R: Resistant, SXT: Trimetoprime-Sulphametoxazole, SAM: Sulbactam-Ampicillin, AMC: Clavulonate-Amoxicillin,  
CRO: Ceftriaxon, CPM: Cefepime, IMP: Imipenem, TOB: Tobramicin, CAZ: Ceftazidime, GM: Gentamicin, CIP: Ciprofloxacin.  
 
DISCUSSION      
   Plasmid-mediated ESβLs pose a worldwide 
resistance problem. These isolates are 
usually resistant to all aminoglycosides, third- 
and fourth-generation cephalosporins and 
monobactams.  Such isolates are involved 
frequently in outbreaks of infection, 
particularly in high-risk areas, such as 
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intensive care or neonatal units.  Since the 
discovery of ESβL-producing coliforms in the 
mid-1980s, over 100 types of different 
enzymes have been described and have 
become a worldwide problem. Thus, the 
members of Enterobacteriaceae producing 
ESβL are a clinical threat and have been 
associated with increasing mortality in 
patients with severe infection. ESβLs are 
mutant enzymes, which derived from TEM or 
SHV (class A) enzymes. They confer variable 
levels of resistance to cefotaxime, ceftazidime 
and other broad-spectrum cephalosporins and 
to monobactams such as aztreonam. Thus, 
the choice of  effective and safe drugs to be 
used against ESβL is shrinking rapidly. 
Therefore, in recent years, researches are 
increasingly turning their attention to folk 
medicine for new leads to develop better 
drugs against clinical ESβL-producing K. 
pneumoniae isolates2,17-19 
In this study, structure-activity relationships do 
not appear to play a role here as all six 
flavonoids exhibited similar MICs (32–64 µg 
ml
-1
) against all of the K. pneumoniae strains.  
We observed that active flavonoids 3–6 have 
an obligatory C–4 keto group and hydroxyl 
group substitutions at C–5 and have at least 
one hydroxyl group on ring B. These results 
are in consonance with the findings of Xu and 
Lee
19
. On the other hand, although the other 
active flavonoids 1 and 2 have methoxyl 
group substitutions at C-5 and C-7, these 
compounds also exhibited antimicrobial 
activity against K. pneumoniae at similar MICs 
values to those of ampicillin and ofloxacin. 
Alcaraz et al and Xu and Lee demonstrated 
that substitution with methoxyl groups 
drastically decreased the antibacterial of 
flavonoids
20,21
. Additionally, it is reported that 
rutin (5) from Linum capitatum Kit. flowers 
inhibited the growth of P. aeruginosa, but did 
not show any activity against E. coli different 
from other Gram-negative bacteria
21
. 
According to the other report, the same 
compound tested by the disc-diffusion method 
showed no activity against K. pneumoniae 
ATCC 13883
20
. These inconsistencies may be 
due to variations within each assay. 
Furthermore, it was not stated whether the 
test flavonoids were obtained from a 
commercial or natural source. 
To the best of our knowledge, this is the first 






naringenin-7-O-β-D-glucopyranoside (4), and 
nicotiflorin (6) against ESβL-producing K. 
pneumoniae isolates.  
 
CONCLUSION 
All the flavonoids (1-6) showed in vitro 
antimicrobial activity against all the isolated 
strains of K. pneumoniae, similar to that 
produced by the control antibacterial 
(ofloxacin) at the concentration of 32-64 µg 
ml
-l
; on the other hand, another control, 
ampicillin, had no activity. To the best of our 
knowledge, this is the first report of the 
evaluation of the activity of these flavonoids 
against (ESβL)-producing K. pneumoniae. On 
the basis of these data presented, these 
flavonoids may be considered potential 
therapeutic compounds for infections that may 
be caused by ESβL-producing bacteria in the 
future. Therefore, further work is under way to 
identify their precise antibacterial mechanism. 
Additionally, the antimicrobial activity of some 
antibacterials in combination with these 
flavonoids against extended-spectrum β-
Lactamase (ESβL)-producing K. pneumoniae 
may also need to be evaluated for the 
treatment of infections caused by ESβL-
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